Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Patiromer Sorbitex Calcium
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Approved
Sponsor : CSL Vifor
Deal Size : Not Applicable
Deal Type : Not Applicable
Veltassa® (patiromer) Approved in Japan For The Treatment of Adults with Hyperkalemia
Details : Veltassa (patiromer sorbitex calcium) is a potassium binder indicated for the treatment of hyperkalemia in adults and pediatric patients ages 12 years and older.
Brand Name : Veltassa
Molecule Type : Small molecule
Upfront Cash : Not Applicable
September 23, 2024
Lead Product(s) : Patiromer Sorbitex Calcium
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Approved
Sponsor : CSL Vifor
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?